These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8630409)
21. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508 [TBL] [Abstract][Full Text] [Related]
22. A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages. Horie R; Ito K; Tatewaki M; Nagai M; Aizawa S; Higashihara M; Ishida T; Inoue J; Takizawa H; Watanabe T Blood; 1996 Oct; 88(7):2422-32. PubMed ID: 8839832 [TBL] [Abstract][Full Text] [Related]
23. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. Hinz M; Lemke P; Anagnostopoulos I; Hacker C; Krappmann D; Mathas S; Dörken B; Zenke M; Stein H; Scheidereit C J Exp Med; 2002 Sep; 196(5):605-17. PubMed ID: 12208876 [TBL] [Abstract][Full Text] [Related]
24. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281 [TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059 [TBL] [Abstract][Full Text] [Related]
26. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. Mathas S; Hinz M; Anagnostopoulos I; Krappmann D; Lietz A; Jundt F; Bommert K; Mechta-Grigoriou F; Stein H; Dörken B; Scheidereit C EMBO J; 2002 Aug; 21(15):4104-13. PubMed ID: 12145210 [TBL] [Abstract][Full Text] [Related]
27. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553 [TBL] [Abstract][Full Text] [Related]
28. Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line. Legrand-Poels S; Schoonbroodt S; Piette J Biochem J; 2000 Aug; 349 Pt 3(Pt 3):765-73. PubMed ID: 10903137 [TBL] [Abstract][Full Text] [Related]
29. CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. Vinante F; Rigo A; Scupoli MT; Pizzolo G Blood; 2002 Jan; 99(1):52-60. PubMed ID: 11756152 [TBL] [Abstract][Full Text] [Related]
30. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. Yan SF; Tritto I; Pinsky D; Liao H; Huang J; Fuller G; Brett J; May L; Stern D J Biol Chem; 1995 May; 270(19):11463-71. PubMed ID: 7744784 [TBL] [Abstract][Full Text] [Related]
31. A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo. Hombach A; Jung W; Pohl C; Renner C; Sahin U; Schmits R; Wolf J; Kapp U; Diehl V; Pfreundschuh M Int J Cancer; 1993 Nov; 55(5):830-6. PubMed ID: 8244580 [TBL] [Abstract][Full Text] [Related]
32. Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking alpha 5 beta 1 integrin. Chen F; Zhang G; Iwamoto Y; See WA J Urol; 2003 Aug; 170(2 Pt 1):605-10. PubMed ID: 12853840 [TBL] [Abstract][Full Text] [Related]
33. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma. Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613 [TBL] [Abstract][Full Text] [Related]
34. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982 [TBL] [Abstract][Full Text] [Related]
35. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246 [TBL] [Abstract][Full Text] [Related]
36. Hodgkin's lymphoma and CD30 signal transduction. Horie R; Higashihara M; Watanabe T Int J Hematol; 2003 Jan; 77(1):37-47. PubMed ID: 12568298 [TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Horie R; Watanabe T; Ito K; Morisita Y; Watanabe M; Ishida T; Higashihara M; Kadin M; Watanabe T Am J Pathol; 2002 May; 160(5):1647-54. PubMed ID: 12000717 [TBL] [Abstract][Full Text] [Related]
38. Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factor. Gruss HJ; Brach MA; Herrmann F Blood; 1992 Nov; 80(10):2563-70. PubMed ID: 1421375 [TBL] [Abstract][Full Text] [Related]
39. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma. Hansen HP; Engels HM; Dams M; Paes Leme AF; Pauletti BA; Simhadri VL; Dürkop H; Reiners KS; Barnert S; Engert A; Schubert R; Quondamatteo F; Hallek M; Pogge von Strandmann E J Pathol; 2014 Mar; 232(4):405-14. PubMed ID: 24659185 [TBL] [Abstract][Full Text] [Related]
40. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]